Clinical Case Reports (Oct 2021)
Metastatic and locally aggressive BCC: Current treatment options
Abstract
Abstract The treatment of locally advanced and metastatic BCC presents a significant clinical challenge. Treatment options have evolved recently to include the use of hedgehog inhibitors Vismodigib and Sonidigib and immunotherapy with Cemiplimab.
Keywords